Revisiting the commercial-academic interface in medical journals

The New England Journal of Medicine goes on an ill advised journey

[1]  F. Godlee,et al.  Medical journals and industry ties , 2014, BMJ : British Medical Journal.

[2]  Lisa Rosenbaum.  Understanding bias--the case for careful study. , 2015, The New England journal of medicine.

[3]  Don A. Moore,et al.  The Dirt on Coming Clean: Perverse Effects of Disclosing Conflicts of Interest , 2003, The Journal of Legal Studies.

[4]  Monique L. Anderson,et al.  Compliance with results reporting at ClinicalTrials.gov. , 2015, The New England journal of medicine.

[5]  Jonathan J. Darrow,et al.  Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs , 2013, Journal of Law, Medicine & Ethics.

[6]  James Topping,et al.  Compliance with results reporting at ClinicalTrials.gov. , 2015, The New England journal of medicine.

[7]  R. Steinbrook,et al.  Justifying conflicts of interest in medical journals: a very bad idea , 2015, BMJ : British Medical Journal.

[8]  Lisa Rosenbaum.  Conflicts of interest: part 1: Reconnecting the dots--reinterpreting industry-physician relations. , 2015, The New England journal of medicine.

[9]  Steven Joffe,et al.  A randomized study of how physicians interpret research funding disclosures. , 2012, The New England journal of medicine.

[10]  Sara Schroter,et al.  Does the type of competing interest statement affect readers' perceptions of the credibility of research? Randomised trial , 2004, BMJ : British Medical Journal.

[11]  J. Drazen.  Revisiting the commercial-academic interface. , 2015, The New England journal of medicine.

[12]  K. Abbasi,et al.  Corruption: medicine’s dirty open secret , 2014, British medical journal.

[13]  Lisa Rosenbaum,et al.  Beyond moral outrage--weighing the trade-offs of COI regulation. , 2015, The New England journal of medicine.